Published in AIDS Weekly, August 18th, 1997
This is the first step in developing a potential treatment for HIV using this technology, said chief executive of Gene Shears Pty Ltd, Dr. Leigh Farrell.
The Phase I clinical trial, conducted at St. Vincent's Hospital, Sydney, Australia, is testing the safety and ability of Gene Shears' patented gene therapy to inhibit HIV replication in infected patients.
The basis for the trial is the original discovery by CSIRO Plant Industry molecular biologists Jim Haseloff and Wayne Gerlach that naturally-occurring enzymes called ribozymes (dubbed "gene...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.